Busaco, Chezelle .
HRN: 25-07-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/28/2025
06/03/2025
IV
145mg
Q6
Periodontal Abscess
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: